|Product Description||Rabbit Polyclonal antibody to TAZ (tafazzin)|
|Background||This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. [provided by RefSeq]|
|Synonyms||BTHS antibody, CMD3A antibody, EFE antibody, EFE2 antibody, FLJ27390 antibody, G4.5 antibody, LVNCX antibody, Taz1 antibody, XAP-2 antibody, TAZ antibody, tafazzin antibody, protein G4.5 antibody|
|Cellular Localization||Isoform 1: Membrane; Single-pass membrane protein , Isoform 2: Cytoplasm , Isoform 3: Membrane; Single-pass membrane protein , Isoform 4: Membrane; Single-pass membrane protein , Isoform 5: Membrane; Single-pass membrane protein , Isoform 6: Cytoplasm , I|
|Immunogen||Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human TAZ. The exact sequence is proprietary.|
|Predicted Cross Reactivity species Predicted cross-reactivity:|
Predicted cross-reactivity is based on sequence homology, with greater than 80% immunogen sequence identity considered positive.
Please note that we are only able to guarantee products to work in applications and species in which they have been tested.
|Predict Reactivity Note||Chimpanzee (100%)|